0ILL fundamentals
An in-depth look to LABORATORIOS FARMACEUTOCOS ROVI SA EUR0.06 operating, investing, and financing activities
0ILL free cash flow for Q4 24 is 46.17 M EUR. For 2024, 0ILL free cash flow was 77.52 M EUR and operating cash flow was 136.64 M EUR.
Q4 '16
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q3 '24
Q4 '24
−100.00 M
−50.00 M
0.00
50.00 M
100.00 M
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q4 '16
Dec 2016
Q1 '17
Mar 2017
Q2 '17
Jun 2017
Q3 '17
Sep 2017
Q4 '17
Dec 2017
Q1 '18
Mar 2018
Q2 '18
Jun 2018
Q3 '18
Sep 2018
Q4 '18
Dec 2018
Q1 '19
Mar 2019
Q2 '19
Jun 2019
Q3 '19
Sep 2019
Q4 '19
Dec 2019
Q1 '20
Mar 2020
Q2 '20
Jun 2020
Q3 '20
Sep 2020
Q4 '20
Dec 2020
Q1 '21
Mar 2021
Q2 '21
Jun 2021
Q3 '21
Sep 2021
Q4 '21
Dec 2021
Q1 '22
Mar 2022
Q2 '22
Jun 2022
Q3 '22
Sep 2022
Q4 '22
Dec 2022
Q1 '23
Mar 2023
Q2 '23
Jun 2023
Q3 '23
Sep 2023
Q4 '23
Dec 2023
Q1 '24
Mar 2024
Q3 '24
Sep 2024
Q4 '24
Dec 2024
TTM
Cash from operating activitiesYoY growth
67.50 M
+490.89%
24.49 M
−76.46%
28.63 M
−56.13%
123.00 K
−76.39%
61.11 M
−9.47%
15.45 M
−36.92%
—
72.52 M
+58,855.28%
—
Cash from investing activitiesYoY growth
−38.80 M
−104.68%
−4.90 M
−132.54%
−13.25 M
−70.56%
−8.90 M
−5.00%
−26.46 M
+31.81%
−9.16 M
−86.80%
—
−41.80 M
−369.46%
—
Cash from financing activitiesYoY growth
−1.39 M
+96.29%
−3.07 M
+96.91%
−3.03 M
−89.03%
−88.66 M
−70.39%
−65.70 M
−4,640.12%
−18.53 M
−503.71%
—
−21.09 M
+76.21%
—
Free cash flowYoY growth
34.89 M
—
19.59 M
−80.79%
15.53 M
−73.00%
−8.13 M
−4.22%
33.56 M
−3.81%
6.59 M
−66.35%
—
46.17 M
—
—